期刊文献+

抗疟活性化合物─3-[4-(7-氯喹啉-4-基)哌嗪-1-基]丙酸的合成与结构鉴定 被引量:2

Synthesis and structure identification of the anti-malarial agent 3-[4-(7-choloquinolin-4-yl) piperazin-1-yl] propanoic acid
原文传递
导出
摘要 目的:合成哌喹的一种活性代谢物3-[4-(7-氯喹啉-4-基)哌嗪-1-基]丙酸。方法:以哌嗪、4,7-二氯喹啉为原料,采用氨基保护、取代、脱保护、水解等反应合成3-[4-(7-氯喹啉-4-基)哌嗪-1-基]丙酸,并结合硅胶柱层析洗脱分离纯化样品。结果:成功制备了3-[4-(7-氯喹啉-4-基)哌嗪-1-基]丙酸,产率为62.1%,其结构并通过IR,1H-NMR,13C-NMR,HRMS图谱加以确证。结论:本合成方法操作简单,产率高,适用于以4-哌嗪基喹啉为母核的一系列衍生物的合成。 Objective: To synthesize 3-[4-(7-choloquinolin-4-yl) piperazin-1-yl] propanoic acid,an active metabolite of piperaquine.Methods: Piperazine was mono-protected with BOC,then reacted with ethyl 3-bromopropanoiate,subsequently deprotection,and substitution with 4,7-dichloroquinoline,and hydrolysis in consequence,afforded 3-[4-(7-choloquinolin-4-yl) piperazin-1-yl] propanoic acid.The target compound was further isolated and purified by silica gel chromatography.Results: 3-[4-(7-choloquinolin-4-yl) piperazin-1-yl] propanoic acid was synthesized successfully and the yield was 62.1%.The structure was confirmed by IR,1H-NMR,13C-NMR and HRMS.Conclusion: The synthesis method is simple,and the yield of 3-[4-(7-choloquinolin-4-yl) piperazin-1-yl] propanoic acid is high,so that it can be used for the synthesis of derivatives containing 4-piperazinyl quinoline ring.
出处 《中国新药杂志》 CAS CSCD 北大核心 2010年第24期2328-2330,共3页 Chinese Journal of New Drugs
关键词 3-[4-(7-氯喹啉-4-基)哌嗪-1-基]丙酸 抗疟活性 全合成 结构鉴定 3-[4-(7-choloquinolin-4-yl) piperazin-1-yl] propanoic acid anti-malarial activitie total synthesis structure identification
  • 相关文献

参考文献8

  • 1苟锦博,冯子键,李华忠,郑灿军,葛军,朱刚,尤芳红,朱东山.磷酸哌喹用于人群疟疾预防服药的副反应调查[J].中国热带医学,2008,8(4):541-543. 被引量:6
  • 2张晶敏,吴蓝鸥,杨恒林,段启祥,师敏,杨照青.云南省疟疾流行情况及药物治疗、抗药性研究现状[J].中国病原生物学杂志,2008,3(12):950-952. 被引量:10
  • 3TARNING J, BERGQVIST Y, DAY NP, et al. Characterization of human urinary metabolites of the antimalarial piperaquine [ J ]. Drug Metab Dispos, 2006 34(12) : 2011 -2019.
  • 4LIU CH, HUANG XT, ZHANG R, et al. Determination of CQP propionic acid in rat plasma and study of pharmacokinetics of CQP propionic acid in rats by liquid chromatography[J]. J Chromatogr B, 2008, 862(1 -2): 189-195.
  • 5PARK JH, CHOI JK, LEE E, et al. Lead discovery and optimization of T-type calcium channel blockers [J]. Bioorg Med Chem, 2007, 15(3) : 1409 -1419.
  • 6ZHENG H, WEINER LM, BAR-AM O, et al. Design, synthesis, and evaluation of novel bifunctional iron-chelators as potential agents for neuroprotection in Alzheimer's, Parkinson's, and other neurodegenerative diseases [J]. Bioorg Med Chem, 2005, 13 (3): 773-783.
  • 7WARHURST DC, CRAIG JC, ADAGU IS, et al. Activity of piperaquine and other 4-aminoquinolie antiplasmodial drugs against chloroquine-sensitive and resistant blood-stages of Plasmodium falciparum Role of b-haematin inhibition and drug concentration in vacuolar water- and lipid-phases[J]. Biochem Pharmacol, 2007, 73(12) : 1910 -1926.
  • 8万伯顺,肖远胜,梁鑫淼,等.一种含氮杂环β-榄香烯哌嗪烷基类衍生物其制备及应用:中国,1318405C[P].2007-05-30.

二级参考文献42

共引文献15

同被引文献17

  • 1郭灿城,李可来,童荣标,陈亮,张晓兵.新型氮芥和卤代烷基哌嗪芳香醛的合成[J].有机化学,2005,25(3):308-312. 被引量:4
  • 2万伯顺,肖远胜,梁鑫淼,等.一种含氮杂环β-榄香烯哌嗪烷基类衍生物其制备及应用:中国,1318405C[P].2007-05-30.
  • 3TIMOTHY J E, ROGER H, ROGER H, et al. Structure function relationships in aminoquinolines: effect of amino and chloro groups on quinoline hematin complex formation inhibition of β-hematin formation, and antiplasmodial activity[ J ]. J Med Chem,2000 ,43 (2) :283 - 291.
  • 4CHIYANZU I, CLARKSON C, PETER J S, et al. Design, synthesis and anti-plasmodial evaluation in vitro of new 4- aminoquinoline isatin derivatives [ J ]. Bioorg Med Chem, 2005,13:3249 - 326.
  • 5CARRIE-ANNE M, MIRIAM K, HAGAI G, et al. Arylpiperazines displayingpreferential potency against chloroquine-resistant strains of the malaria parasite plasmodium falciparum [ J ]. Biochem Pharmacol, 2005,71 : 61 -68.
  • 6宋光富 彭黔荣 杨敏等.1-烷基-2-甲基咪唑衍生物的高效简便合成.精细与专用化学品,2004,.
  • 7YASUHIRO I, TAKANOBU K, HIROKI S, et al. Discovery of imidazo [ 1,5-c] imidazol-3-ones weakly basic, orally active factor xa inhibitors [J]. J Med Chem, 2008,51:3422 - 3436.
  • 8LIU Yan-qing, ZHOU En-kun, YU Kun-qian, et al. Discovery of a novel CCR5 antagonist lead compound through fragment assembly[J]. Molecules, 2008, 13 :2426 -2441.
  • 9邓福娟,鲁仲平.浅谈西咪替丁的抗肿瘤作用及应用[J].中国医疗前沿,2009,4(10):133-134. 被引量:1
  • 10肖丹,龙泳,王善青.国内外疟疾疫情的研究进展[J].中国热带医学,2010,10(1):113-115. 被引量:8

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部